Current Perspectives in NSAID-Induced Gastropathy
Author(s) -
M. Sinha,
L. Gautam,
Prakash Shukla,
Punit Kaur,
Sujata Sharma,
T.P. Singh
Publication year - 2013
Publication title -
mediators of inflammation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.37
H-Index - 97
eISSN - 1466-1861
pISSN - 0962-9351
DOI - 10.1155/2013/258209
Subject(s) - medicine , antipyretic , analgesic , nonsteroidal , misoprostol , adverse effect , side effect (computer science) , drug , cyclooxygenase , pharmacology , intensive care medicine , limiting , antiinflammatory drug , proton pump inhibitor , chemistry , pregnancy , mechanical engineering , biochemistry , enzyme , abortion , biology , computer science , engineering , genetics , programming language
Nonsteroidal anti-inflammatory drugs (NSAIDs) are the most highly prescribed drugs in the world. Their analgesic, anti-inflammatory, and antipyretic actions may be beneficial; however, they are associated with severe side effects including gastrointestinal injury and peptic ulceration. Though several approaches for limiting these side effects have been adopted, like the use of COX-2 specific drugs, comedication of acid suppressants like proton pump inhibitors and prostaglandin analogs, these alternatives have limitations in terms of efficacy and side effects. In this paper, the mechanism of action of NSAIDs and their critical gastrointestinal complications have been reviewed. This paper also provides the information on different preventive measures prescribed to minimize such adverse effects and analyses the new suggested strategies for development of novel drugs to maintain the anti-inflammatory functions of NSAIDs along with effective gastrointestinal protection.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom